ReviewMedGenMed : Medscape general medicine2007
Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders.
Review in MedGenMed : Medscape general medicine, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 57 citations in OpenAlex.
- Low-dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials.Clinical & experimental optometry · 2019Trial
- Efficacy of olopatadine hydrochloride 0.1%, emedastine difumarate 0.05%, and loteprednol etabonate 0.5% for Chinese children with seasonal allergic conjunctivitis: a randomized vehicle-controlled study.International forum of allergy & rhinology · 2017Trial
- [New and future treatment approaches for allergic conjunctivitis].Die Ophthalmologie · 2024Review
- Brazilian guidelines for the monitoring and treatment of pediatric allergic conjunctivitis.Arquivos brasileiros de oftalmologia · 2021Article
- Trends in licence approvals for ophthalmic medicines in the United Kingdom.Eye (London, England) · 2020Article
- The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2019Review
- Review
- Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis.Journal of asthma and allergy · 2018Article
- Allergic conjunctivitis: a comprehensive review of the literature.Italian journal of pediatrics · 2013Review
- Efficacy of mometasone furoate and fluticasone furoate on persistent allergic rhinoconjunctivitis.Allergy & rhinology (Providence, R.I.) · 2013Article
- The anatomical and functional relationship between allergic conjunctivitis and allergic rhinitis.Allergy & rhinology (Providence, R.I.) · 2013Article
- Intranasal corticosteroids: do they improve ocular allergy?Current allergy and asthma reports · 2009Article
- Safety and efficacy of sodium cromoglycate-fluorometholone fixed combination eye drops in allergic conjunctivitis.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological SocietyArticle
- Dermatoparasitoses in Referral Patients to the Laboratory.Iranian journal of parasitologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextAllergy symptoms that affect the eyes are common in adults and children worldwide, and are often associated with nasal allergy symptoms, prompting the term 'rhinoconjunctivitis' to describe the condition. However, this condition has not always been recognized, and earlier literature reported allergic conjunctivitis only within a subset of nasal allergy patients. EVIDENCE ACQUISITION: To assess the current state of ocular allergy epidemiology, pathophysiology, and currently available treatment options, we performed a MEDLINE search for articles regarding ocular allergy, rhinoconjunctivitis, vernal keratoconjunctivitis (VKC), atopic keratoconjunctivitis (AKC), and giant papillary conjunctivitis (GPC). EVIDENCE SYNTHESIS: The more severe forms of ocular allergy are not only distressing, but can also threaten a patient's vision. Each type of ocular allergy is associated with ocular redness, itching, and tearing; however, AKC and VKC can threaten the cornea, and research has revealed that involvement of different immune cell populations (mast cells, eosinophils, and lymphocytes) may cause these more severe symptoms. A variety of treatment options exist to control ocular allergy symptoms. Nonpharmacologic options include allergen avoidance and lubrication with saline, and if these fail to be sufficiently effective, symptom relief may be provided by medicinal agents that are either applied topically to the eye or taken orally. Recent evidence suggests that nasal allergy treatments applied topically to the nose may also positively affect ocular allergy symptoms, which raises the interesting possibility that a parasympathetic nasal-ocular neural reflex pathway may be involved in the stimulation of allergic responses in the eye.
conclusionsOcular allergy is underdiagnosed and has a significant impact on the life of the patient. It is vital to reach a better understanding of ocular allergic mechanisms and inflammation, which may lead to improved treatment.
Indexed as
Identifiers
18092041PMC2100110W1483928772What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.